FDA Inspection 1230391 — Perrigo New York, Inc.

Perrigo New York, Inc. — FEI 2450054

The FDA completed an inspection of Perrigo New York, Inc. on September 17, 2024 in Bronx, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 17, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bronx, NY (United States)